150 related articles for article (PubMed ID: 34997910)
1. Polypharmacy and prescription medication use in a population-based sample of adolescent and young adult cancer survivors.
Betts AC; Murphy CC; Shay LA; Balasubramanian BA; Markham C; Allicock M
J Cancer Surviv; 2023 Aug; 17(4):1149-1160. PubMed ID: 34997910
[TBL] [Abstract][Full Text] [Related]
2. Polypharmacy and medication fill nonadherence in a population-based sample of adolescent and young adult cancer survivors, 2008-2017.
Betts AC; Murphy CC; Shay LA; Balasubramanian BA; Markham C; Roth ME; Allicock M
J Cancer Surviv; 2023 Dec; 17(6):1688-1697. PubMed ID: 36346577
[TBL] [Abstract][Full Text] [Related]
3. Polypharmacy and patterns of prescription medication use among cancer survivors.
Murphy CC; Fullington HM; Alvarez CA; Betts AC; Lee SJC; Haggstrom DA; Halm EA
Cancer; 2018 Jul; 124(13):2850-2857. PubMed ID: 29645083
[TBL] [Abstract][Full Text] [Related]
4. Substance use, substance use disorders, and treatment in adolescent and young adult cancer survivors-Results from a national survey.
Ji X; Cummings JR; Mertens AC; Wen H; Effinger KE
Cancer; 2021 Sep; 127(17):3223-3231. PubMed ID: 33974717
[TBL] [Abstract][Full Text] [Related]
5. Burden of multimorbidity and polypharmacy among cancer survivors: a population-based nested case-control study.
Keats MR; Cui Y; DeClercq V; Grandy SA; Sweeney E; Dummer TJB
Support Care Cancer; 2021 Feb; 29(2):713-723. PubMed ID: 32444894
[TBL] [Abstract][Full Text] [Related]
6. Impacts of the Early COVID-19 Pandemic Among a National Sample of Adolescent and Young Adult Cancer Survivors in the United States.
Betts AC; Shay LA; Allicock M; Preston SM; Grimes A; Murphy CC
J Adolesc Young Adult Oncol; 2023 Jun; 12(3):324-330. PubMed ID: 36173754
[No Abstract] [Full Text] [Related]
7. Polypharmacy and medication use by cancer history in a nationally representative group of adults in the USA, 2003-2014.
Hsu CD; Nichols HB; Lund JL
J Cancer Surviv; 2022 Jun; 16(3):659-666. PubMed ID: 34032998
[TBL] [Abstract][Full Text] [Related]
8. Use of Chronic Prescription Medications and Prevalence of Polypharmacy in Survivors of Childhood Cancer.
Ewig CLY; Cheng YM; Li HS; Wong JCL; Cho AHY; Poon FMH; Li CK; Cheung YT
Front Oncol; 2021; 11():642544. PubMed ID: 33869032
[TBL] [Abstract][Full Text] [Related]
9. Short- and long-term impact of cancer on employment and financial outcomes of adolescents and young adults (AYAs): a large population-based case-control registry study in the Netherlands.
Janssen SHM; van der Meer DJ; van Eenbergen MCHJ; Manten-Horst E; van der Graaf WTA; Husson O
ESMO Open; 2022 Aug; 7(4):100521. PubMed ID: 35772237
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of Low-Cost Generic Program Use in a Nationally Representative Cohort of Privately Insured Adults.
Pauly NJ; Brown JD
J Manag Care Spec Pharm; 2015 Dec; 21(12):1162-70. PubMed ID: 26679965
[TBL] [Abstract][Full Text] [Related]
11. Psychotropic polypharmacy and its association with health-related quality of life among cancer survivors in the USA: a population-level analysis.
Vyas A; Alghaith G; Hufstader-Gabriel M
Qual Life Res; 2020 Aug; 29(8):2029-2037. PubMed ID: 32207028
[TBL] [Abstract][Full Text] [Related]
12. National Patterns in Prescription Opioid Use and Misuse Among Cancer Survivors in the United States.
Jairam V; Yang DX; Verma V; Yu JB; Park HS
JAMA Netw Open; 2020 Aug; 3(8):e2013605. PubMed ID: 32804217
[TBL] [Abstract][Full Text] [Related]
13. Association between polypharmacy and health-related quality of life among cancer survivors in the United States.
Babcock ZR; Kogut SJ; Vyas A
J Cancer Surviv; 2020 Feb; 14(1):89-99. PubMed ID: 31792811
[TBL] [Abstract][Full Text] [Related]
14. Changes in Opioid Prescriptions and Potential Misuse and Substance Use Disorders Among Childhood Cancer Survivors Following the 2016 Opioid Prescribing Guideline.
Hu X; Brock KE; Effinger KE; Zhang B; Graetz I; Lipscomb J; Ji X
JAMA Oncol; 2022 Nov; 8(11):1658-1662. PubMed ID: 36074473
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life in adolescents and young adults with and without cancer, using propensity score matching.
Choi E; Becker H; Jung H
J Cancer Surviv; 2023 Apr; 17(2):279-289. PubMed ID: 34850323
[TBL] [Abstract][Full Text] [Related]
16. Early Posttherapy Opioid Prescription, Potential Misuse, and Substance Use Disorder Among Pediatric Cancer Survivors.
Ji X; Hu X; Brock KE; Mertens AC; Cummings JR; Effinger KE
J Natl Cancer Inst; 2022 Jun; 114(6):895-906. PubMed ID: 35262708
[TBL] [Abstract][Full Text] [Related]
17. Additional medical costs of chronic conditions among adolescent and young adult cancer survivors.
Abdelhadi OA; Joseph J; Pollock BH; Keegan THM
J Cancer Surviv; 2022 Jun; 16(3):487-496. PubMed ID: 33899161
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with polypharmacy and the prescription of multiple medications among persons living with HIV (PLWH) compared to non-PLWH.
Moore HN; Mao L; Oramasionwu CU
AIDS Care; 2015; 27(12):1443-8. PubMed ID: 26608408
[TBL] [Abstract][Full Text] [Related]
19. Preferences for exercise and physical activity support in adolescent and young adult cancer survivors: a cross-sectional survey.
Adams SC; Petrella A; Sabiston CM; Vani MF; Gupta A; Trinh L; Matthew AG; Hamilton RJ; Mina DS
Support Care Cancer; 2021 Jul; 29(7):4113-4127. PubMed ID: 33409722
[TBL] [Abstract][Full Text] [Related]
20. Connecting with healthcare providers at diagnosis: adolescent/young adult cancer survivors' perspectives.
Phillips CR; Haase JE; Broome ME; Carpenter JS; Frankel RM
Int J Qual Stud Health Well-being; 2017 Dec; 12(1):1325699. PubMed ID: 28617094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
